Evidence map›Paper›PMID 40980788›Full record

ArticleCureus2025

A Fatal Case of Anti-PL-7 Antibody-Associated Rapidly Progressive Interstitial Lung Disease Complicated by Tuberculosis: A Case Report.

Junko Itano, Goro Kimura

Erratum issuedAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Junko ItanoDepartment of Allergy and Respiratory Medicine, National Hospital Organization (NHO) Okayama Medical Center, Okayama, JPN.
Goro KimuraDepartment of Allergy and Respiratory Medicine, National Hospital Organization (NHO) Okayama Medical Center, Okayama, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The anti-PL-7 antibody is an anti-aminoacyl-tRNA synthetase antibody. Patients who test positive for anti-PL-7 antibodies present with various clinical symptoms, including myositis, polyarthritis, and interstitial lung disease (ILD). The anti-PL-7 antibody also causes rapidly progressive ILD (RP-ILD), which may be fatal. In this report, we present the case of a 92-year-old woman with anti-PL-7 antibody-positive RP-ILD, complicated by

Indexed as

anti-pl-7 antibodyimmunosuppressive treatmentinterstitial lung diseasemycobacterium tuberculosisrapidly progressive interstitial lung disease

Identifiers

PMID40980788
PMCPMC12447662

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.